Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Pizzuti

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Anticancer Research|August 19, 2007
Immunohistochemical expression and prognostic significance of fatty acid synthase in pancreatic carcinomaPiero L Alo, Mostafa Amini, Francesca Piro, et al.
Cancer Treatment Reviews|March 31, 2015
Metformin and breast cancer: basic knowledge in clinical contextLaura Pizzuti, Patrizia Vici, Luigi Di Lauro, et al.
Breast Cancer Research and Treatment|August 29, 2013
Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancerLuigi Di Lauro, Patrizia Vici, Pietro Del Medico, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 27, 2014
Immunologic treatments for precancerous lesions and uterine cervical cancerPatrizia Vici, Luciano Mariani, Laura Pizzuti, et al.
Expert Reviews in Molecular Medicine|July 3, 2015
The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implicationsMarcello Maugeri-Saccà, Maddalena Barba, Laura Pizzuti, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 17, 2013
FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohortMarcello Maugeri-Saccà, Laura Pizzuti, Domenico Sergi, et al.
Critical Reviews in Oncology/Hematology|September 18, 2016
Presurgical window of opportunity trial design as a platform for testing anticancer drugs: Pros, cons and a focus on breast cancerMarcello Maugeri-Saccà, Maddalena Barba, Patrizia Vici, et al.
Cancer Letters|August 16, 2015
Androgen receptor and antiandrogen therapy in male breast cancerLuigi Di Lauro, Maddalena Barba, Laura Pizzuti, et al.
Critical Reviews in Oncology/Hematology|December 4, 2020
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectivesDaniele Marinelli, Raffaele Giusti, Marco Mazzotta, et al.
The Breast Journal|March 7, 2021
COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experienceMaddalena Barba, Eriseld Krasniqi, Laura Pizzuti, et al.
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Anticancer Research|August 19, 2007
Immunohistochemical expression and prognostic significance of fatty acid synthase in pancreatic carcinomaPiero L Alo, Mostafa Amini, Francesca Piro, et al.
Cancer Treatment Reviews|March 31, 2015
Metformin and breast cancer: basic knowledge in clinical contextLaura Pizzuti, Patrizia Vici, Luigi Di Lauro, et al.
Breast Cancer Research and Treatment|August 29, 2013
Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancerLuigi Di Lauro, Patrizia Vici, Pietro Del Medico, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 27, 2014
Immunologic treatments for precancerous lesions and uterine cervical cancerPatrizia Vici, Luciano Mariani, Laura Pizzuti, et al.
Expert Reviews in Molecular Medicine|July 3, 2015
The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implicationsMarcello Maugeri-Saccà, Maddalena Barba, Laura Pizzuti, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 17, 2013
FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohortMarcello Maugeri-Saccà, Laura Pizzuti, Domenico Sergi, et al.
Critical Reviews in Oncology/Hematology|September 18, 2016
Presurgical window of opportunity trial design as a platform for testing anticancer drugs: Pros, cons and a focus on breast cancerMarcello Maugeri-Saccà, Maddalena Barba, Patrizia Vici, et al.
Cancer Letters|August 16, 2015
Androgen receptor and antiandrogen therapy in male breast cancerLuigi Di Lauro, Maddalena Barba, Laura Pizzuti, et al.
Critical Reviews in Oncology/Hematology|December 4, 2020
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectivesDaniele Marinelli, Raffaele Giusti, Marco Mazzotta, et al.
The Breast Journal|March 7, 2021
COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experienceMaddalena Barba, Eriseld Krasniqi, Laura Pizzuti, et al.
Pageof 12